Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: phase I, dose-escalation study findings
by Hummel, Horst-Dieter (Author)
, Kufer, Peter (Author)
, Grüllich, Carsten (Author)
, Seggewiss-Bernhardt, Ruth (Author)
, Deschler-Baier, Barbara (Author)
, Chatterjee, Manik (Author)
, Goebeler, Maria-Elisabeth (Author)
, Miller, Kurt (Author)
, de Santis, Maria (Author)
, Loidl, Wolfgang (Author)
, Dittrich, Christian (Author)
, Buck, Andreas (Author)
, Lapa, Constantin Frederik Victor (Author)
, Thurner, Annette (Author)
, Wittemer-Rump, Sabine (Author)
, Koca, Gökben (Author)
, Boix, Oliver (Author)
, Döcke, Wolf-Dietrich (Author)
, Finnern, Ricarda (Author)
, Kusi, Helena (Author)
, Ajavon-Hartmann, Antoinette (Author)
, Stienen, Sabine (Author)
, Sayehli, Cyrus Michael (Author)
, Polat, Bülent (Author)
, Bargou, Ralf C. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource